CAR T Cell Therapy Market To Reach USD 39.9 Billion By 2032, Says DataHorizzon Research
07. Mai 2024 03:10 ET
|
DataHorizzon Research
Fort Collins, Colorado, May 07, 2024 (GLOBE NEWSWIRE) -- The growing prevalence of cancer is a prominent factor in the development of CAR T Cell therapy. The increasing prevalence of cancer...